Lung Cancer News

Sotorasib exhibited durable efficacy among certain adults with locally advanced or metastatic non-small cell lung cancer, according to study results presented at American Association for Cancer Research Annual Meeting.

Although smoking cessation is known to benefit patients with cancer, obstacles exist at the patient, clinician and institutional levels, according to a poster presentation at American Association for Cancer Research Annual Meeting.

Use of an immune checkpoint inhibitor within 90 days of radiation therapy did not increase risk for serious adverse events among patients with cancer, according to a pooled analysis of prospective trial data published in JAMA Oncology.

Self-reported signs of distress and an increasing total Edmonton Symptom Assessment System score within 180 days of cancer diagnosis appeared associated with higher odds of nonfatal, self-inflicted injury, study results showed.

Individuals whose underlying poor health may make them less likely to benefit from lung cancer screening appeared more likely to undergo the scans than those with better health status, according to study results in JAMA Network Open.

A blood-based signature of five microRNAs demonstrated the ability to predict OS of patients with lung cancer receiving immunotherapy and stratify them for treatment, according to a study published in npj Precision Oncology.

A wait time of at least 20 days to undergo elective, low-risk, cancer-related surgery appeared safe following recovery from mild to moderate COVID-19, according to study results published in Annals of Surgical Oncology.

A randomized phase 3 trial designed to assess the addition of tiragolumab to atezolizumab and chemotherapy for extensive-stage small cell lung cancer failed to meet its co-primary endpoint of PFS.

The racial gap in timely surgery between Black and white patients with early-stage lung cancer improved after an antiracism intervention, according to study results published in Journal of Clinical Oncology.

Black patients with cancer had worse COVID-19 outcomes than white patients, according to results of a retrospective cohort study published in JAMA Network Open.